Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Ossium Health, Inc.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
University of Nebraska
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Bellicum Pharmaceuticals
PrECOG, LLC.
Columbia University
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Cellerant Therapeutics
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
National Cancer Institute (NCI)
University of California, San Francisco
Duke University
Fred Hutchinson Cancer Center